Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Cell Genesys (CEGE)
(
)
Quote & Articles
Transcripts
Instablogs
StockTalks
Comments on articles
Cramer
Authors on CEGE
Newest on CEGE
The Burrill Report
(1)
VFC's Stock House
(1)
EP Vantage
(1)
MidnightTrader.com
(1)
Mike Huckman
(2)
Most frequent on CEGE
Alan Brochstein
(
7
)
Centient Biotech Investor
(
6
)
Michael Shulman
(
3
)
Stockerblog
(
2
)
Ohad Hammer
(
2
)
Most followed on CEGE
Alan Brochstein
(
537
)
Stockerblog
(
316
)
VFC's Stock House
(
246
)
Mike Huckman
(
211
)
Ohad Hammer
(
124
)
Most commented on CEGE
Michael Shulman
(
17
)
Alan Brochstein
(
15
)
Ohad Hammer
(
8
)
Mike Huckman
(
6
)
Stockerblog
(
3
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on Cell Genesys (CEGE)
by
latest
|
most commented
Dealmaking Sweeps the Biotech Sector
Jul 5
•
The Burrill Report
•
BIIB
,
BPA
,
ACOR
•
Comment!
|
Quick Read
Cell Genesys: BioSante Sees Something Other than Cash
Jul 1
•
EP Vantage
•
CEGE
,
BPA
•
Comment!
|
Quick Read
Closing Update for Tuesday June 30
Jun 30
•
MidnightTrader.com
•
ASTM
,
APOL
,
ABT
•
Comment!
|
Quick Read
4 Small Cap Stock Briefs
Jun 24
•
VFC's Stock House
•
CEGE
,
CPST
,
INSM
•
2 Comments
|
Quick Read
Five Biopharma Companies Drop on Negative Drug News
Aug 28, 2008
•
Mike Huckman
•
CEGE
,
BMY
,
AMLN
•
1 Comment
|
Quick Read
Six Significant Gene Therapy Stocks
May 13, 2008
•
Stockerblog
•
CEGE
,
ALNY
,
ENZ
•
2 Comments
|
Quick Read
Antigenics, Dendreon and Cell Genesys Find Hope in Overseas Treatment Approvals
Apr 11, 2008
•
Michael Shulman
•
CEGE
,
AGEN
,
DNDN
•
6 Comments
|
Quick Read
Russian Roulette Pays Off for Antigenics
Apr 9, 2008
•
Mike Huckman
•
CEGE
,
AGEN
,
DNDN
•
5 Comments
|
Quick Read
Which Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys?
Apr 4, 2008
•
Michael Shulman
•
CEGE
,
C
,
PRAN
•
11 Comments
|
Quick Read
Amgen: Boxed In
Jan 7, 2008
•
Michael Shulman
•
CEGE
,
AMGN
•
Comment!
|
Quick Read
Cell Genesys Searches for Prostate Cancer Cure
Dec 23, 2007
•
Jeff Bishop
•
CEGE
•
Comment!
|
Quick Read
Cell Genesys’ GVAX: A Multi-Trick Pony
Jul 30, 2007
•
Ohad Hammer
•
CEGE
•
8 Comments
|
Quick Read
Cancer Stocks: Tracking the Market
Jul 9, 2007
•
Alan Brochstein
•
ANX
,
ACEL
,
AFFY
•
Comment!
|
Quick Read
Cancer Stocks: The Bleeding Slows
Jul 2, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
Comment!
|
Quick Read
Cancer Stocks Hammered Once Again
Jun 26, 2007
•
Alan Brochstein
•
AFFY
,
AGEN
,
ABPI
•
7 Comments
|
Quick Read
Cancer Stocks Slide Again
Jun 18, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
1 Comment
|
Quick Read
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
3 Comments
|
Quick Read
Cell Genesys Should Not Be Trading In Tandem With Dendreon
Jun 6, 2007
•
Steven T. Gold
•
CEGE
,
DNDN
•
Comment!
|
Quick Read
Cancer Stocks Soar With Annual ASCO Meeting
Jun 4, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
1 Comment
|
Quick Read
Cancer Stocks on the Go: Winners and Losers
May 29, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
3 Comments
|
Quick Read
Cell Genesys: The Promise of GVAX
May 7, 2007
•
Ohad Hammer
•
CEGE
•
Comment!
|
Quick Read
7 Companies Searching to Treat or Cure Parkinson's
Apr 25, 2007
•
Stockerblog
•
NVS
,
CEGE
,
ACAD
•
1 Comment
|
Quick Read
Biotech Day In Review: Genentech Beats Estimates Slightly
Apr 12, 2007
•
Centient Biotech Investor
•
CEGE
,
DNA
,
CELG
•
1 Comment
|
Quick Read
Russell 3000's Best and Worst Stocks, Week and Year to Date
Apr 8, 2007
•
TickerSense
•
CEGE
,
DF
,
AGIX
•
Comment!
|
Quick Read
Biotech Day In Review: Cell Genesys Climbs On GVAX Results
Apr 4, 2007
•
Centient Biotech Investor
•
CEGE
,
ELN
,
LGND
•
Comment!
|
Quick Read
Biotech Week In Review: Barron’s Touts Alzheimers Drugs From Wyeth
Apr 2, 2007
•
Centient Biotech Investor
•
BEC
,
AMGN
,
BPA
•
1 Comment
|
Quick Read
Will Dendreon's Cancer Vaccine Win Final Approval?
Mar 31, 2007
•
Centient Biotech Investor
•
CEGE
,
DNDN
•
Comment!
|
Quick Read
Biotech Day in Review: Allergan Expands Obesity Franchise
Feb 23, 2007
•
Centient Biotech Investor
•
CEGE
,
DNA
,
AGN
•
Comment!
|
Quick Read
Renaissance Technologies: "Black-Box" Hedge Fund Discloses New Positions
Feb 13, 2007
•
Lon Juricic
•
CEGE
,
BRCD
,
AVCI
•
Comment!
|
Quick Read
Biotech Stocks Day-In-Review: Amgen Rises On Speculation Over Patent Suit
Jan 23, 2007
•
Centient Biotech Investor
•
CEGE
,
AMGN
,
AZN
•
1 Comment
|
Quick Read